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Immunisation has contributed greatly to human development. 
Immunisation saves more than 2.5 million lives a year, and could 
prevent an additional 2 million deaths a year with increased coverage 
and use of newer vaccines.[1] For immunisation programmes to sustain 
the impact made in the control of vaccine-preventable diseases and 
contribute to the attainment of sustainable development goals on 
health, an uninterrupted supply of quality vaccines maintained in the 
right cold chain to facilities where children are vaccinated is crucial. 
Interruption at any point in the supply chain results in stock-outs in 
all levels below; consequently, children are turned away without being 
vaccinated. This has serious implications for the health system, as 
vaccines are essential drugs and should be available at facilities that 
provide immunisation services at all times. 
Reports point to vaccine shortages especially since the introduc-
tion of three new vaccines (rotavirus vaccine (RV), pneumococcal 
conjugate vaccine (PCV) and DTaP-IPV//Hib, a vaccine combination 
of five antigens referred to as Pentaxim), which are single doses. 
Reports include direct complaints from the public to the national and 
provincial departments of health offices, and newspaper reports. The 
post-introduction evaluation of the new vaccines conducted in all 
nine provinces by the Expanded Programme on Immunisation (EPI), 
with the support of the World Health Organization (WHO), found 
that more than 60% of facilities visited had experienced vaccine 
shortages in the 18-month period between the end of 2009 and July 
2011.[2] Between April 2010 and March 2011, over 221 000 children 
who received the measles vaccine at 9 months old did not get the 
third dose of PCV that should have been given at the same time with 
the measles vaccine. All provinces and districts including Tshwane in 
Gauteng Province had vaccine stock-outs. 
The Stop Stock Outs Project (SSP) reports that in 2015, 11% of 
facilities countrywide reported shortages of at least one vaccine 
on the day of contact. Most facilities reported stock-out of the 
hexavalent (DTaP-IPV-Hib-HBV) vaccine. SSP further reports 
outliers, such as Limpopo Province, where 28% of facilities reported 
vaccine stock-out on the day of contact.[3] The South African 
Health Review 2011[4]  refers to frequent stock-outs of drugs in the 
Essential Drugs List due to poor management. It points out that the 
introduction of new services such as antiretroviral (ARV) therapy 
and new vaccines have exposed inadequate infrastructure at facility 
level, resulting in poor service.  
The impact of introducing new vaccines and the resultant stock-
outs have been experienced by a number of countries. For example, 
the introduction of rotavirus vaccine in Latin American countries 
such as Brazil, Ecuador, El Salvador and Venezuela in 2006/2007 
resulted in frequent vaccine stock-outs in clinics.[5]
Vaccine shortages do not only undermine national efforts towards 
universal access to healthcare services, but they also have far-
reaching consequences, which include an increased likelihood of 
disease outbreaks. It should be noted that Pentaxim, which has 
been replaced by the hexavalent, is not a new vaccine but merely a 
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Background. Vaccines have greatly contributed to the control of vaccine-preventable diseases and to human development. Efforts by 
many countries to introduce new vaccines are a significant move towards achieving the sustainable development goal for health. However, 
effective vaccine supply chains that ensure an uninterrupted supply of vaccines are pivotal to attaining universal access to life-saving 
vaccines and sustainable development. The introduction of new vaccines puts a strain on supply chains; South Africa (SA) is no exception, 
as there are indications of vaccine stock-outs in clinics. 
Objective. To establish the status of vaccine availability and associated factors in government health facilities of Tshwane Health District in 
Gauteng Province, SA.
Methods. A cross-sectional study was conducted in a sample of randomly selected government clinics in the Tshwane health district of 
Gauteng Province. Data were collected using a structured measurement instrument in participating clinics. Data were analysed using Excel-
based software (Microsoft, USA). 
Results. A total of 31 clinics participated. In the preceding 12 months, clinics had experienced vaccine stock-outs, especially of the three 
newer vaccines: pneumococcal conjugate vaccine, rotavirus and Pentaxim. These were also out of stock for a long duration; for over 2 weeks 
in a majority of clinics. The causes of vaccine stock-outs were: poor management of stock, district depot out of stock, unreliable deliveries, 
lack of pharmacy assistants and limited fridge capacity. Further burdening the situation is the ineffective emergency-ordering system. 
Conclusion. Significant shortages of vaccines, which are essential drugs, occur in Tshwane government clinics. Vaccine supply chain issues 
and vaccine shortages should be treated as a priority at all levels of the healthcare system; therefore, a similar study should be conducted 
at national level. It is recommended that the vaccine supply chain should be restructured and overhauled with the use of advances in 
technology and could be linked with current initiatives such as MomConnect.
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newer formulation. Pentaxim shortages meant that children were not 
protected against infections that had previously been under control. 
This could result in outbreaks of these conditions. 
Literature is scarce on vaccine availability in government facilities, 
the extent of probable vaccine shortages and their causes. This study 
examined the extent and factors associated with vaccine stock-outs in 
government facilities in Tshwane Health District in Gauteng Province 
over a period of 1 year.  Its objective was to establish the status of 
vaccine availability and associated factors in government health 
facilities of Tshwane Health District in Gauteng Province.
Methods 
This was a cross-sectional survey of a sample of randomly selected 
government clinics in Tshwane Health District. The District Health 
Information System was the sampling frame. There are 75 primary 
healthcare clinics in Tshwane Health District; 32 facilities were 
sampled. The district office provided support by informing facility 
managers of the study; with this support and repeated phone calls to 
facilities requesting participation and setting up appointments, 31 of 
the 32 sampled facilities participated in the study. 
The study was conducted over 2 weeks in December 2013. The 
principal investigator collected data by conducting interviews and 
a physical check of vaccine stock in participating clinics, using a 
structured measurement instrument. Questions were mainly of the 
closed type or used the Likert scale. Questions focused on: stock 
management; availability of a pharmacist or pharmacist assistants; 
stock delivery and emergency orders; fridge capacity; supervision; 
and the impact of the higher level of the healthcare system. Questions 
in relation to stock-out elicited: whether there were vaccine stock 
shortages on the day of the visit; whether there had been vaccine 
stock shortages in the last 12 months; which vaccines were out of 
stock; and the duration of stock-out. A few open-ended questions 
allowed for comments on opinion and experiences.  
The Nelson Mandela Metropolitan University (NMMU) Unit for 
Statistical Consultation used in-house Excel-based (Microsoft, USA) 
statistical software to analyse the data. 
Ethical approval was obtained from the Tshwane Health District 
Committee on Research (project number 45/2013 – Clearance 
Certificate). Ethical clearance was also obtained from the Human 
Research Ethics Committee of NMMU (ref. no. H13-BES-BS-010). 
Results 
Thirty-one of the 75 government primary healthcare facilities in 
Tshwane Health District participated, which covered the east, central 
and north regions. Respondents were the facility manager, the 
vaccinator, the pharmacist or pharmacist assistant, or the supervisor. 
On the day of the visit, 11 items were out of stock in 9 (29%) of 
31 clinics. These included rotavirus and measles vaccines, Pentaxim, 
measles diluent, tetanus and low strength diphtheria and tetanus (Td) 
and syringes. Practically all vaccines had been out of stock over different 
periods in the preceding 12 months in participating clinics (Table 1). 
All clinics had experienced a shortage of at least one vaccine in the 
preceding 12 months. Vaccine shortages lasted from <2 days to >2 
weeks (Figs 1 - 3).  
Table 1. Number of  clinics experiencing shortages of a 
particular vaccine in the preceding 12 months
Vaccine Clinics with stock, N=31, n (%)
Pentaxim 23 (74)
PCV 20 (65)
Rotavirus 18 (58)
Hepatitis B 16 (52)
Other 15 (48)
Measles 5 (16) Fig. 3. Frequency distribution of the duration of Pentaxim stock-outs in 23 
clinics experiencing stock-out of this vaccine in the previous 12 months.
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Fig. 1. Frequency distribution of the duration of PCV stock-outs in 20 clinics.
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Fig. 2. Frequency distribution of the duration of RV stock-outs in 18 clinics.
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Vaccine shortages were attributed to a number of reasons, which were 
not mutually exclusive. Reasons included delays in delivery, depot 
being out of stock, orders reduced by the district depot and shortage 
of vehicles to collect vaccines. 
Clinics reported that the district depot reduced the quantities and 
supplied fewer doses than ordered. Only six (19%) of the 31 clinics 
positively indicated that their orders were not reduced. The vaccines 
that were most likely to be reduced by the depot were Pentaxim, PCV 
and RV, in that descending order. 
Nineteen clinics had limited fridge capacity. Statistical analysis did 
not find an association between inadequate fridge capacity and vaccine 
shortage. 
Clinics used stock cards to manage vaccine stock. Challenges with 
stock management contributed to stock shortages. Stock cards that 
correctly reflected the stock at hand were observed in 16 (52%) clinics. 
Stock cards indicated zero balances in the previous 12 months, which 
was in keeping with stock shortages.  
There were delays in delivery of pharmaceuticals. Although all 
clinics have an emergency ordering system, emergency orders took up 
to a week or more to be delivered (Table 2). 
Of the 31 clinics, 18 (58%) had a health worker – a pharmacist, 
pharmacy assistant or enrolled nurse – dedicated to the management 
of pharmaceuticals, including vaccines. Statistical analysis revealed 
a significant association between the presence of a pharmacist or 
pharmacist assistants and the duration of vaccine stock-outs. The 
clinics without pharmacists or assistants were more likely to be out of 
stock of vaccines for longer periods than clinics that had them. None 
of the health workers responsible for vaccines, including pharmacists, 
had specific training on vaccine stock management. 
Enrolled nurses who were assigned the responsibility of management 
of pharmaceuticals stated their resentment and frustration with this 
responsibility. It was observed in two facilities that vaccines were left 
in the boxes in which they were delivered for 2 - 3 days without being 
unpacked; no one took on this responsibility. This was observed in 
facilities without a pharmacist assistant, and was more likely to occur 
when vaccines were delivered on a Friday or just before a long weekend. 
Supervision is conducted monthly in 24 (77%) clinics, quarterly in 6 
(19%) and weekly in 1 clinic (3%). All 31 clinics indicated that specific 
EPI supervision was conducted. Only two clinics reported financial 
constraints as a possible cause of vaccine shortages. Nineteen (61%) 
indicated that there were no financial or budgetary issues. 
In response to stock-outs, clinics borrow vaccines from the nearest 
clinics. 
On pre-warning about impending shortages, three clinics reported 
that the depot had warned them of vaccine stock shortages, which 
was communicated by the national suppliers. None of the clinics had 
been able to warn users of health services in advance of expected stock 
shortages. 
Discussion 
The study findings point to significant shortages of vaccines in 
government clinics in Tshwane Health District. Shortages of vaccines 
are a serious national challenge and negate the national EPI policy 
statements that ‘every day is an immunisation day’ and ‘every child 
that is well enough to go home, should go home immunised’.[6] These 
policy statements imply that there are sufficient quantities of vaccines 
at all times in all clinics and other healthcare facilities. 
The findings of serious vaccine shortages are in keeping with those 
of the SSP.[3] However, the proportion of facilities that are out of stock 
are lower in the SSP study – 11% compared with 29% in this study. 
This could be due to different methodologies; the SSP study was 
based on phone calls, while in this study facilities were visited and 
there were physical inspections of vaccines. 
Shortages appear to have become more of a challenge since the 
introduction of the newer vaccines Pentaxim, PCV and RV, in 
keeping with findings of Zaffran et al.[7] Zaffran et al. point out that 
the new vaccines are expensive, and packed in bulky pre-packed 
single dose presentations. This study also found that the newer 
vaccines were likely to have a longer duration of stock-out than other 
vaccines, 1 - 2 weeks or more in duration. This may be in keeping 
with the observation that these vaccines take up too much cold chain 
space, overwhelm the supply chains and lead to stock-outs.[7,8]  
By contrast, the measles vaccine was out of stock in only five 
clinics, and the hepatitis B vaccine was out of stock in 16 clinics, 
despite the national shortages of hepatitis B and measles vaccines that 
were announced by the national suppliers about 3 or 4 months before 
the study was conducted (personal communication with National 
Department of Health). 
Apart from the new vaccines and their demand on the cold chain, 
many other factors play a role in the shortages of vaccines. There 
seems to be no single factor that causes vaccine stock-outs. Rodewald 
et al.[9] came to a similar conclusion in ascertaining the causes of 
vaccine supply problems in the USA. This also applies to stock-outs 
of drugs in general, as highlighted by a study on drug shortages in 
the USA.[10] Furthermore, there may be an issue with the cost of the 
newer vaccines, which this study did not investigate. 
Management issues are significant, and relate to: supervision that 
fails to anticipate and address stock-outs; stock management and 
timing of stock orders; the district depot being out of stock and 
reducing orders; delays in delivery; ineffective emergency ordering 
systems; and human resources for pharmaceuticals. These causes of 
vaccine shortages are not limited to EPI, and nor are they limited to 
facility level or a specific facility. The SSP survey had similar findings, 
as it found shortages of essential drugs. This points to weaknesses of 
the health system that undermine efforts aimed at effective service 
delivery.
There are different levels of challenges; clinics have challenges of 
poor stock management indicated by zero balances in the stock card, 
stock cards that are not up to date and failure to produce stock cards. 
At district and subdistrict levels, challenges include: supervision; 
delays in delivery of stock; cutting down on quantities ordered, which 
may not take into account head counts at facilities; and ineffective 
emergency-ordering systems. An emergency-ordering system that 
takes up to a week or more is a cause for concern. Supervision does 
not achieve what it should; although conducted monthly in over 
74% of clinics, it still fails to address basic challenges such as vaccine 
shortages. This is in keeping with the findings of the Health Systems 
Trust in the District Health Barometer 2008/2009.[11]
Human resources for the management of pharmaceuticals at 
facility level are also a concern. Enrolled nurses assigned the 
responsibility for pharmaceuticals deeply resent this responsibility 
and do the absolute minimum. There is little support from the 
district depot, resulting in the neglect of pharmaceuticals. Further 
complications are that it takes longer for these facilities to realise 
Table 2. The period from placing to receiving an emergency order
Period 
Clinics
 (N=31), n (%)
1 day  5 (16)
2 - 3 days  12 (39)
>3 days - 1 week  9 (29)
>1 week  5 (16)
Total  31 (100)
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that they have shortages, and they are unlikely to quickly address 
shortages by borrowing, which many other facilities do. The fact 
that they are not trained in vaccine stock management further 
compromises the situation.
The lack of effective mechanisms to pre-warn facilities on existing 
or expected shortages and to inform the users of healthcare facilities 
about the vaccine stock situation should be addressed. Effective 
communication can help to lessen the impact of shortages. The lack 
of communication, complicated by the inability to ascertain when 
stock is likely to be available, further impacts negatively on service 
delivery, and compromises clients, as it may result in repeated clinic 
visits and being turned away. 
The use of stock cards for stock management at facility level deserves 
further consideration. This system is outdated and does not add value 
to the supply chain in the current era of technological advancement. 
Technology allows for the linking of the various levels of the supply 
chain and for tracing of products as to where they are in the supply 
chain, and can set up systems that generate automatic orders and 
can activate alarms when critical stock levels are reached. Stock cards 
do not allow for this kind of monitoring. One clinic used computer 
software to manage pharmaceutical stock, including vaccines.  
It is therefore worth noting that the vaccine supply system has 
not been updated, and the different stages of the chain and location 
of depots remain as they were more than 20 - 30 years ago. A 
similar observation is made by Humphrey,[12] pointing out that the 
introduction of new vaccines has put unprecedented strain on the 
delivery and logistics systems that have remained the same and have 
not been upgraded over a number of decades.
With the recent changes in the EPI and the switch from Pentaxim 
to Hexaxim (a six-antigen-in-one vaccine, which includes hepatitis 
B) in 2015, and the changes in measles vaccine, concentrated 
efforts are required to ensure an uninterrupted supply of vaccines. 
Furthermore, the diphtheria outbreak in KwaZulu-Natal[13] might 
have been a result of shortages of Pentaxim, which is likely to have 
occurred over a period of time and resulted in many children being 
susceptible to previously controlled infections. 
Study limitations
The study was limited to Tshwane government clinics. It did not focus 
on finances, and there was no specific focus on other consumables 
such as needles and syringes. Data were collected over a short period 
in December, and this timing could have had an effect on the results.
Conclusion and recommendations
Significant vaccine shortages occur in Tshwane government clinics 
and last for up to more than 2 weeks, and predominantly affect the 
availability of three relatively new vaccines.  
The causes of vaccine shortages in clinics are many and relate to: 
(i) supply chain and challenges at higher levels; and (ii) factors at 
clinic level which include a lack of committed and supported officials. 
These findings point to management failure at district, subdistrict 
and facility levels. 
Considering that vaccines are essential drugs, their shortages have 
serious implications for the functioning of the healthcare system. It is 
recommended that vaccine supply-chain issues and shortages should 
be treated as a priority at all levels of the healthcare system. A similar 
study at national level is urgently required to establish the situation 
with the availability of vaccines in health facilities and supplying 
depots.
Efforts to improve management of health facilities and systems 
should address the challenges identified, including: timely delivery of 
pharmaceuticals; handling of emergency orders; communication on 
expected stock shortages; effective supervision; and human resources 
for stock management at facility level. 
It is critical that the stock management and information system 
be overhauled, and the system should link the district depot to 
each facility, taking into consideration head counts at facility level. 
Efforts should be made to improve communication with the users 
of healthcare facilities. Current initiatives such as the SSP should 
be supported, and the MomConnect initiative that has a reminder 
system for pregnant women to attend healthcare facilities could 
be linked to efforts aimed at monitoring and addressing vaccine 
shortages.
Tshwane district management would benefit from appointing a 
vaccine supply-chain logistician, whose responsibilities would include 
focused support of facilities. 
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